Single-Nucleotide Polymorphism–Microarray Ploidy Analysis of Paraffin-Embedded Products of Conception in Recurrent Pregnancy Loss Evaluations
Authors:
- Tara BudinetzTBTara Budinetz
- Carolina SueldoCSCarolina Sueldo
- Erica AnspachEAErica Anspach
- Lawrence EngmannLELawrence Engmann
- Claudio BenadivaCBClaudio Benadiva
- John C. NulsenJNJohn C. Nulsen
- 1 July 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 126 (1) , 175-181
Abstract
To compare the analysis of chromosome number from paraffin-embedded products of conception using single-nucleotide polymorphism (SNP) microarray with the recommended screening for the evaluation of couples presenting with recurrent pregnancy loss who do not have previous fetal cytogenetic data. We performed a retrospective cohort study including all women who presented for a new evaluation of recurrent pregnancy loss over a 2-year period (January 1, 2012, to December 31, 2013). All participants had at least two documented first-trimester losses and both the recommended screening tests and SNP microarray performed on at least one paraffin-embedded products of conception sample. Single-nucleotide polymorphism microarray identifies all 24 chromosomes (22 autosomes, X, and Y). Forty-two women with a total of 178 losses were included in the study. Paraffin-embedded products of conception from 62 losses were sent for SNP microarray. Single-nucleotide polymorphism microarray successfully diagnosed fetal chromosome number in 71% (44/62) of samples, of which 43% (19/44) were euploid and 57% (25/44) were noneuploid. Seven of 42 (17%) participants had abnormalities on recurrent pregnancy loss screening. The per-person detection rate for a cause of pregnancy loss was significantly higher in the SNP microarray (0.50; 95% confidence interval [CI] 0.36–0.64) compared with recurrent pregnancy loss evaluation (0.17; 95% CI 0.08–0.31) (P=.002). Participants with one or more euploid loss identified on paraffin-embedded products of conception were significantly more likely to have an abnormality on recurrent pregnancy loss screening than those with only noneuploid results (P=.028). The significance remained when controlling for age, number of losses, number of samples, and total pregnancies. These results suggest that SNP microarray testing of paraffin-embedded products of conception is a valuable tool for the evaluation of recurrent pregnancy loss in patients without prior fetal cytogenetic results. Recommended recurrent pregnancy loss screening was unnecessary in almost half the patients in our study. IIKeywords
This publication has 23 references indexed in Scilit:
- Concurrent ovarian and ipsilateral tubal ectopic pregnancies after a double embryo transfer: a case reportJournal of Assisted Reproduction and Genetics, 2014
- Genomic Imbalance in Products of ConceptionObstetrics & Gynecology, 2014
- Miscarriage chromosome testing: utility of comparative genomic hybridization with reflex microsatellite analysis in preserved miscarriage tissueFertility and Sterility, 2014
- Rescue karyotyping: a case series of array-based comparative genomic hybridization evaluation of archival conceptual tissueReproductive Biology and Endocrinology, 2014
- Evaluation and treatment of recurrent pregnancy loss: a committee opinionFertility and Sterility, 2012
- Cost-effectiveness of cytogenetic evaluation of products of conception in the patient with a second pregnancy lossFertility and Sterility, 2012
- Is chromosome testing of the second miscarriage cost saving? A decision analysis of selective versus universal recurrent pregnancy loss evaluationFertility and Sterility, 2012
- Informatics Enhanced SNP Microarray Analysis of 30 Miscarriage Samples Compared to Routine CytogeneticsPLOS ONE, 2012
- Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy lossesFertility and Sterility, 2010
- Embryonic karyotype of abortuses in relation to the number of previous miscarriagesFertility and Sterility, 2000